OLR1 and cancer: Likewise, the activation of NF-κB by oxLDL/LOX-1-ROS could induce the secretion of IL-6 observed in our study, which in turn may act in an autocrine fashion to stimulate STAT3 signaling, as it has been observed in other types of cancer [73].